WallStSmart

Itron Inc (ITRI)vsMKS Instruments Inc (MKSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 74% more annual revenue ($4.07B vs $2.35B). ITRI leads profitability with a 12.3% profit margin vs 8.0%. ITRI appears more attractively valued with a PEG of 0.72. MKSI earns a higher WallStSmart Score of 61/100 (C+).

ITRI

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 6.5Value: 6.0Quality: 7.5
Piotroski: 4/9Altman Z: 1.79

MKSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 3.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ITRISignificantly Overvalued (-22.8%)

Margin of Safety

-22.8%

Fair Value

$81.31

Current Price

$80.07

$1.24 premium

UndervaluedFair: $81.31Overvalued
MKSISignificantly Overvalued (-75.4%)

Margin of Safety

-75.4%

Fair Value

$147.68

Current Price

$301.65

$153.97 premium

UndervaluedFair: $147.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ITRI4 strengths · Avg: 8.5/10
Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.728/10

Growing faster than its price suggests

P/E RatioValuation
12.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

MKSI2 strengths · Avg: 9.0/10
EPS GrowthGrowth
53.2%10/10

Earnings expanding 53.2% YoY

Revenue GrowthGrowth
15.2%8/10

15.2% revenue growth

Areas to Watch

ITRI3 concerns · Avg: 2.7/10
Altman Z-ScoreHealth
1.794/10

Distress zone — elevated risk

Revenue GrowthGrowth
-3.3%2/10

Revenue declined 3.3%

EPS GrowthGrowth
-16.9%2/10

Earnings declined 16.9%

MKSI2 concerns · Avg: 2.0/10
P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ITRI

The strongest argument for ITRI centers on Debt/Equity, PEG Ratio, P/E Ratio. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bull Case : MKSI

The strongest argument for MKSI centers on EPS Growth, Revenue Growth. Revenue growth of 15.2% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : ITRI

The primary concerns for ITRI are Altman Z-Score, Revenue Growth, EPS Growth.

Bear Case : MKSI

The primary concerns for MKSI are P/E Ratio, Altman Z-Score. A P/E of 74.6x leaves little room for execution misses.

Key Dynamics to Monitor

ITRI profiles as a declining stock while MKSI is a growth play — different risk/reward profiles.

MKSI carries more volatility with a beta of 2.00 — expect wider price swings.

MKSI is growing revenue faster at 15.2% — sustainability is the question.

ITRI generates stronger free cash flow (79M), providing more financial flexibility.

Bottom Line

MKSI scores higher overall (61/100 vs 57/100) and 15.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Itron Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Itron, Inc., a technology and services company, offers end-to-end solutions that help manage energy, water, and smart city operations globally. The company is headquartered in Liberty Lake, Washington.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?